MENU
CHE
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

CHE stock forecast, quote, news & analysis

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value... Show more

CHE
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
a Summary for CHE with price predictions
Aug 14, 2026

CHE's RSI Indicator recovers from overbought zone

The 10-day RSI Indicator for CHE moved out of overbought territory on August 11, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 instances where the indicator moved out of the overbought zone. In of the 41 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 68 cases where CHE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CHE turned negative on August 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CHE broke above its upper Bollinger Band on July 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CHE advanced for three days, in of 326 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 191 cases where CHE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.389) is normal, around the industry mean (238.711). P/E Ratio (26.805) is within average values for comparable stocks, (131.068). Projected Growth (PEG Ratio) (2.156) is also within normal values, averaging (1.749). Dividend Yield (0.004) settles around the average of (0.014) among similar stocks. P/S Ratio (2.837) is also within normal values, averaging (2.693).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CHE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.

A.I.Advisor
published Dividends

CHE is expected to pay dividends on September 03, 2026

Chemed Corp CHE Stock Dividends
A dividend of $0.70 per share will be paid with a record date of September 03, 2026, and an ex-dividend date of August 17, 2026. The last dividend of $0.60 was paid on June 16. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH), WW International Inc (NASDAQ:WW).

Industry description

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

Market Cap

The average market capitalization across the Hospital/Nursing Management Industry is 4.79B. The market cap for tickers in the group ranges from 48.5K to 87.61B. HCA holds the highest valuation in this group at 87.61B. The lowest valued company is BYZN at 48.5K.

High and low price notable news

The average weekly price growth across all stocks in the Hospital/Nursing Management Industry was -0%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 47%. AVAH experienced the highest price growth at 30%, while AIRS experienced the biggest fall at -32%.

Volume

The average weekly volume growth across all stocks in the Hospital/Nursing Management Industry was -20%. For the same stocks of the Industry, the average monthly volume growth was -19% and the average quarterly volume growth was -26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 50
Price Growth Rating: 50
SMR Rating: 65
Profit Risk Rating: 88
Seasonality Score: -17 (-100 ... +100)
View a ticker or compare two or three
CHE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a holding medical company

Industry HospitalNursingManagement

Profile
Details
Industry
Medical Or Nursing Services
Address
255 East Fifth Street
Phone
+1 513 762-6690
Employees
15087
Web
https://www.chemed.com
CHE's RSI Indicator recovers from overbought zone